Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study-Reference-Cited by-同舟云学术

Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study

Published:2015-02-05 Issue:4 Volume:138 Page:963-973
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Svenningsson Per,Rosenblad Carl,af Edholm Arvidsson Karolina,Wictorin Klas,Keywood Charlotte,Shankar Bavani,Lowe David A.,Björklund Anders,Widner Håkan

Publisher

Oxford University Press (OUP)

Subject

Clinical Neurology

Link

http://academic.oup.com/brain/article-pdf/138/4/963/13798742/awu409.pdf

Reference36 articles.

1. Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease;Bara-Jimenez;Mov Disord,2005

2. AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials;Berg;Mov Disord,2011

3. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia;Bezard;Mov Disord,2013

4. Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models;Bibbiani;Neurology,2001

5. Buspirone in levodopa-induced dyskinesias;Bonifati;Clin Neuropharmacol,1994

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome;International Journal of Molecular Sciences;2024-08-13

2. 5-HT4R agonism reduces L-DOPA-induced dyskinesia via striatopallidal neurons in unilaterally 6-OHDA lesioned mice;Neurobiology of Disease;2024-08

3. Serotonergic Regulation of Synaptic Dopamine Levels Mitigates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease;Journal of Parkinson's Disease;2024-07-23

4. 5-HT1B receptors mediate dopaminergic inhibition of vesicular fusion and GABA release from striatonigral synapses;2024-03-14

5. Novel and experimental therapeutics for the management of motor and non-motor Parkinsonian symptoms;Neurological Sciences;2024-02-23